You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 5, May 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Multiple Sclerosis/ Demyelinating Disease
 •Neurology, Other
 •Radiologic Imaging
 •Magnetic Resonance Imaging
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Diffusely Abnormal White Matter in Chronic Multiple Sclerosis

Imaging and Histopathologic Analysis

Alexandra Seewann, MD; Hugo Vrenken, PhD; Paul van der Valk, MD; Erwin L. A. Blezer, PhD; Dirk L. Knol, PhD; Jonas A. Castelijns, MD; C. H. Polman, MD; Petra J. W. Pouwels, PhD; Frederik Barkhof, MD; Jeroen J. G. Geurts, PhD

Arch Neurol. 2009;66(5):601-609.

Background  Diffuse abnormalities in the white matter (WM), ie, the so-called diffusely abnormal WM (DAWM), as observed on magnetic resonance imaging (MRI), may contribute to the development of clinical disability in multiple sclerosis (MS). Underlying pathologic and MRI characteristics of DAWM are largely unknown.

Objectives  To explore and describe the histopathologic and radiologic characteristics of DAWM in chronic MS.

Design  An MRI and histopathologic postmortem correlative study.

Methods  We analyzed 17 formalin-fixed hemispheric brain slices from 10 patients with chronic MS using histopathologic analysis and qualitative and quantitative MRI. A region-of-interest approach was applied to compare radiologically defined DAWM, normal-appearing WM, and focal WM lesions and to correlate quantitative MRI measures with histopathologic findings.

Main Outcome Measures  The DAWM consisted of extensive axonal loss, decreased myelin density, and chronic fibrillary gliosis, all of which were substantially abnormal compared with normal-appearing WM and significantly different from focal WM lesion pathology. Increased T1- and T2-relaxation times and decreased fractional anisotropy values were found in DAWM regions of interest, in association with extensive axonal loss and reduced myelin density. Increased T1- and T2-relaxation times were associated with chronic gliosis.

Conclusions  This study classifies DAWM in chronic MS as an abnormality that is different from normal-appearing WM and focal WM lesions, most likely resulting from the cumulative effects of ongoing inflammation and axonal pathology. As such, DAWM is likely to substantially contribute to disease progression and may prove to be an important new disease marker in clinical trials focusing on the neurodegenerative aspects of MS.


Author Affiliations: Departments of Neurology (Drs Seewann and Polman), Radiology (Drs Vrenken, Castelijns, Barkhof, and Geurts), Pathology (Drs van der Valk and Geurts), Epidemiology and Biostatistics (Dr Knol), and Physics and Medical Technology (Drs Vrenken and Pouwels), VU University Medical Center, Amsterdam, the Netherlands; Image Sciences Institute, University Medical Center Utrecht, the Netherlands (Dr Blezer), and Department of Neurology, Medical University of Graz, Austria (Dr Seewann).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2009;66(5):552-553.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.